400 related articles for article (PubMed ID: 30606408)
41. The FGF23 and Klotho system beyond mineral metabolism.
Kuro-O M
Clin Exp Nephrol; 2017 Mar; 21(Suppl 1):64-69. PubMed ID: 27838783
[TBL] [Abstract][Full Text] [Related]
42. Elevated fibroblast growth factor 23 exerts its effects on placenta and regulates vitamin D metabolism in pregnancy of Hyp mice.
Ohata Y; Yamazaki M; Kawai M; Tsugawa N; Tachikawa K; Koinuma T; Miyagawa K; Kimoto A; Nakayama M; Namba N; Yamamoto H; Okano T; Ozono K; Michigami T
J Bone Miner Res; 2014 Jul; 29(7):1627-38. PubMed ID: 24470103
[TBL] [Abstract][Full Text] [Related]
43. Genetic Ablation of Fgf23 or Klotho Does not Modulate Experimental Heart Hypertrophy Induced by Pressure Overload.
Slavic S; Ford K; Modert M; Becirovic A; Handschuh S; Baierl A; Katica N; Zeitz U; Erben RG; Andrukhova O
Sci Rep; 2017 Sep; 7(1):11298. PubMed ID: 28900153
[TBL] [Abstract][Full Text] [Related]
44. Klotho/FGF23 and Wnt Signaling as Important Players in the Comorbidities Associated with Chronic Kidney Disease.
Muñoz-Castañeda JR; Rodelo-Haad C; Pendon-Ruiz de Mier MV; Martin-Malo A; Santamaria R; Rodriguez M
Toxins (Basel); 2020 Mar; 12(3):. PubMed ID: 32188018
[TBL] [Abstract][Full Text] [Related]
45. Dysregulated Mineral Metabolism in AKI.
Leaf DE; Christov M
Semin Nephrol; 2019 Jan; 39(1):41-56. PubMed ID: 30606407
[TBL] [Abstract][Full Text] [Related]
46. Diagnostic accuracy of fibroblast growth factor 23 for predicting acute kidney injury in patients with acute decompensated heart failure.
Pramong N; Gojaseni P; Suttipongkeat S; Kiattisunthorn K; Chittinandana A
Nephrology (Carlton); 2021 Feb; 26(2):126-133. PubMed ID: 32902010
[TBL] [Abstract][Full Text] [Related]
47. Fibroblast Growth Factor 23 Levels Associate with AKI and Death in Critical Illness.
Leaf DE; Jacob KA; Srivastava A; Chen ME; Christov M; Jüppner H; Sabbisetti VS; Martin A; Wolf M; Waikar SS
J Am Soc Nephrol; 2017 Jun; 28(6):1877-1885. PubMed ID: 28028134
[TBL] [Abstract][Full Text] [Related]
48. The emerging role of the fibroblast growth factor-23-klotho axis in renal regulation of phosphate homeostasis.
Razzaque MS; Lanske B
J Endocrinol; 2007 Jul; 194(1):1-10. PubMed ID: 17592015
[TBL] [Abstract][Full Text] [Related]
49. Reciprocal control of 1,25-dihydroxyvitamin D and FGF23 formation involving the FGF23/Klotho system.
Prié D; Friedlander G
Clin J Am Soc Nephrol; 2010 Sep; 5(9):1717-22. PubMed ID: 20798257
[TBL] [Abstract][Full Text] [Related]
50. Parathyroid Klotho and FGF-receptor 1 expression decline with renal function in hyperparathyroid patients with chronic kidney disease and kidney transplant recipients.
Krajisnik T; Olauson H; Mirza MA; Hellman P; Akerström G; Westin G; Larsson TE; Björklund P
Kidney Int; 2010 Nov; 78(10):1024-32. PubMed ID: 20686451
[TBL] [Abstract][Full Text] [Related]
51. Therapeutic potential of klotho-FGF23 fusion polypeptides: WO2009095372.
Razzaque MS
Expert Opin Ther Pat; 2010 Jul; 20(7):981-5. PubMed ID: 20459364
[TBL] [Abstract][Full Text] [Related]
52. Plasma FGF23 levels increase rapidly after acute kidney injury.
Christov M; Waikar SS; Pereira RC; Havasi A; Leaf DE; Goltzman D; Pajevic PD; Wolf M; Jüppner H
Kidney Int; 2013 Oct; 84(4):776-85. PubMed ID: 23657144
[TBL] [Abstract][Full Text] [Related]
53. The importance of klotho in phosphate metabolism and kidney disease.
Tan SJ; Smith ER; Hewitson TD; Holt SG; Toussaint ND
Nephrology (Carlton); 2014 Aug; 19(8):439-49. PubMed ID: 24750549
[TBL] [Abstract][Full Text] [Related]
54. The potential roles of FGF23 and Klotho in the prognosis of renal and cardiovascular diseases.
Bernheim J; Benchetrit S
Nephrol Dial Transplant; 2011 Aug; 26(8):2433-8. PubMed ID: 21543658
[TBL] [Abstract][Full Text] [Related]
55. FGF23 and Klotho in relation to markers of endothelial dysfunction in kidney transplant recipients.
Malyszko J; Koc-Zorawska E; Matuszkiewicz-Rowinska J; Malyszko J
Transplant Proc; 2014 Oct; 46(8):2647-50. PubMed ID: 25380886
[TBL] [Abstract][Full Text] [Related]
56. Prediction of mortality and need for renal replacement therapy in patients of acute kidney injury using fibroblast growth factor 23.
Fayed A; Radwan WA; Amin M; Gamal A
Saudi J Kidney Dis Transpl; 2019; 30(5):1044-1051. PubMed ID: 31696842
[TBL] [Abstract][Full Text] [Related]
57. [CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). Role of FGF23-Klotho axis in CKD-MBD].
Komaba H
Clin Calcium; 2010 Jul; 20(7):1028-36. PubMed ID: 20585181
[TBL] [Abstract][Full Text] [Related]
58. [Correlations of FGF23 and Klotho with cardiovascular injury in chronic kidney disease patients].
Gan L; Zhou Q
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Sep; 42(9):1058-1065. PubMed ID: 28989152
[TBL] [Abstract][Full Text] [Related]
59. Fibroblast Growth Factor 23 Associates with Death in Critically Ill Patients.
Leaf DE; Siew ED; Eisenga MF; Singh K; Mc Causland FR; Srivastava A; Alp Ikizler T; Ware LB; Ginde AA; Kellum JA; Palevsky PM; Wolf M; Waikar SS
Clin J Am Soc Nephrol; 2018 Apr; 13(4):531-541. PubMed ID: 29519954
[TBL] [Abstract][Full Text] [Related]
60. The Klotho gene family as a regulator of endocrine fibroblast growth factors.
Kurosu H; Kuro-O M
Mol Cell Endocrinol; 2009 Feb; 299(1):72-8. PubMed ID: 19063940
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
